Why Kazakhstan

Kazakhstan has been prioritizing the development of its healthcare sector, with the government allocating a significant budget to the country’s healthcare sector, emphasizing preventive measures, and enhancing medical personnel training.

The market for medical equipment in Kazakhstan is substantial, with the sector accounting for roughly 2.9% of the country's GDP in 2020 and the market for medical equipment being approximately USD 1.3 billion.

The Kazakhstani government has approved the State Program for the Development of Healthcare 2020-2025, indicating a long-term commitment to the growth and improvement of the healthcare sector.

Kazakhstan heavily relies on imported medical equipment, with 90% of the equipment being imported, presenting an opportunity for collaboration with local healthcare companies to address this dependency.

Working with local healthcare companies in Kazakhstan can provide insights into meeting diverse patients' needs better, as emphasized by GSK Kazakhstan LLP.

Kazakhstan is home to innovative health and medical startups such as COGNITELLECT, Retina project, and Kale, which can offer unique collaboration opportunities and access to cutting-edge technologies.

Kazakhstani Government is committed to making market products affordable and available to more people around the world through responsible pricing, strategic access programs, and partnerships, indicating a focus on accessibility and affordability.

GSK Kazakhstan LLP emphasizes ethical standards, ensuring the quality, safety, and reliable supply of products, which can be beneficial for potential collaborations.

Major international biotech and pharmaceutical companies such as Sanofi, GSK, Bayer, Pfizer, and others have a presence in Kazakhstan, indicating the country's potential as a hub for healthcare-related collaborations.